Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 7, 2014, Pages 3983-3990

  Liao, Yu Ting ^a   Kuo, Shu Chen ^a,b   Lee, Yi Tzu ^a,c   Chen, Chien Pei ^c   Lin, Shu Wen ^d   Shen, Li Jiuan ^d   Fung, Chang Phone ^a,c   Cho, Wen Long ^a,e   Chen, Te Li ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM; IMIPENEM; TICARCILLIN; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; BETA-LACTAMASE OXA-58, ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; HYDROLYSIS; MIXED INFECTION; MOUSE; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; WESTERN BLOTTING; ACINETOBACTER INFECTIONS; ANIMAL; BACTERIAL COUNT; BACTERIAL INFECTION; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOLOGY; PLASMID; PNEUMONIA, BACTERIAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BACTERIAL INFECTIONS; BETA-LACTAMASES; COCULTURE TECHNIQUES; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PNEUMONIA, BACTERIAL;

EID: 84903161847     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02636-13     Document Type: Article

References (38)

1. Singer M. 2010. Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease. Virulence 1:10-18. http://dx.doi.org/10. 4161/viru.1.1.9933.
2. Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. 2012. Polymicrobial interactions: impact on pathogenesis and human disease. Clin. Microbiol. Rev. 25:193-213. http://dx.doi.org/10.1128/CMR.00013-11.
3. Bakaletz LO. 2004. Developing animal models for polymicrobial diseases. Nat. Rev. Microbiol. 2:552-568. http://dx.doi.org/10.1038/nrmicro928. (Pubitemid 39200030)
4. Armbruster CE, Hong W, Pang B, Weimer KE, Juneau RA, Turner J, Swords WE. 2010. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. mBio 1(3):e00102-10. http://dx.doi.org/10.1128/mBio.00102-10.
5. Pittet D, Li N, Wenzel RP. 1993. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur. J. Clin. Microbiol. Infect. Dis. 12:813-819. http://dx.doi.org/10.1007/BF02000400. (Pubitemid 24001419)
6. Zheng YL, Wan YF, Zhou LY, Ye ML, Liu S, Xu CQ, He YQ, Chen JH. 2013. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. Am. J. Infect. Control 41:e59-e63. http://dx.doi.org/10.1016/j.ajic.2013.01.006.
7. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
8. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951. http://dx.doi.org/10.1038/nrmicro1789. (Pubitemid 350131182)
9. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836. http://dx.doi.org/10.1111/j.1469-0691.2006.01456.x. (Pubitemid 44151282)
10. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. 2009. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:5035-5038. http://dx.doi.org/10.1128/AAC.00856- 09.
11. Lee YT, Kuo SC, Yang SP, Lin YT, Tseng FC, Chen TL, Fung CP. 2012. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin. Infect. Dis. 55:209-215. http://dx.doi.org/10.1093/cid/cis385.
12. Lee YC, Huang YT, Tan CK, Kuo YW, Liao CH, Lee PI, Hsueh PR. 2011. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J. Antimicrob. Chemother. 66:1839-1846. http://dx.doi.org/10.1093/jac/dkr200.
13. Trottier V, Namias N, Pust DG, Nuwayhid Z, Manning R, Marttos AC, Jr, Dunham MB, Schulman CI, McKenney MG. 2007. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg. Infect. (Larchmt.) 8:437-443. http://dx.doi.org/10.1089/sur.2006.029. (Pubitemid 47493521)
14. Levin BR, Rozen DE. 2006. Non-inherited antibiotic resistance. Nat. Rev. Microbiol. 4:556-562. http://dx.doi.org/10.1038/nrmicro1445. (Pubitemid 43905615)
15. OXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital. Antimicrob. Agents Chemother. 52:4115-4120. http://dx.doi.org/10.1128/AAC.00366- 08.
16. Rumbo C, Fernandez-Moreira E, Merino M, Poza M, Mendez JA, Soares NC, Mosquera A, Chaves F, Bou G. 2011. Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55:3084-3090. http://dx.doi.org/10.1128/AAC.00929-10.
17. Brook I. 2009. The role of beta-lactamase-producing-bacteria in mixed infections. BMC Infect. Dis. 9:202. http://dx.doi.org/10.1186/1471-2334-9-202.
18. Chen TL, Siu LK, Wu RC, Shaio MF, Huang LY, Fung CP, Lee CM, Cho WL. 2007. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin. Microbiol. Infect. 13:801-806. http://dx.doi.org/10.1111/j.1469-0691.2007. 01744.x. (Pubitemid 47039914)
19. OXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in Acinetobacter genomic species 13TU. Antimicrob. Agents Chemother. 54:3107-3112. http://dx.doi.org/10.1128/AAC.00128-10.
20. Lee YT, Huang LY, Chiang DH, Chen CP, Chen TL, Wang FD, Fung CP, Siu LK, Cho WL. 2009. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int. J. Antimicrob. Agents 34:580-584. http://dx.doi.org/10. 1016/j.ijantimicag.2009.06.027.
21. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - 9th ed. M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
22. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing: 24th informational supplement M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
23. Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J. 2007. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J. Clin. Microbiol. 45:453-460. http://dx.doi.org/10.1128/JCM.01971-06.
24. Chen-Chih Wu R, Shaio MF, Cho WL. 2007. A p38 MAP kinase regulates the expression of the Aedes aegypti defensin gene in mosquito cells. Insect Mol. Biol. 16:389-399. http://dx.doi.org/10.1111/j.1365-2583.2007.00734.x. (Pubitemid 47094267)
25. OXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob. Agents Chemother. 52:2573-2580. http://dx.doi.org/10.1128/AAC.00393- 08.
26. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258:72-77. http://dx.doi.org/10. 1111/j.1574-6968.2006.00195.x.
27. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35:322-332. http://dx.doi.org/10.1016/j.ijantimicag.2009.12.011.
28. Tashiro Y, Yawata Y, Toyofuku M, Uchiyama H, Nomura N. 2013. Interspecies interaction between Pseudomonas aeruginosa and other microorganisms. Microbes Environ. 28:13-24. http://dx.doi.org/10.1264/jsme2.ME12167.
29. Schaar V, Nordstrom T, Morgelin M, Riesbeck K. 2011. Moraxella catarrhalis outer membrane vesicles carry beta-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob. Agents Chemother. 55:3845-3853. http://dx.doi.org/10. 1128/AAC.01772-10.
30. Dubey GP, Ben-Yehuda S. 2011. Intercellular nanotubes mediate bacterial communication. Cell 144:590-600. http://dx.doi.org/10.1016/j.cell.2011.01.015.
31. Bernier SP, Letoffe S, Delepierre M, Ghigo JM. 2011. Biogenic ammonia modifies antibiotic resistance at a distance in physically separated bacteria. Mol. Microbiol. 81:705-716. http://dx.doi.org/10.1111/j.1365-2958.2011.07724.x.
32. Pages JM, Anba J, Lazdunski C. 1987. Conditions leading to secretion of a normally periplasmic protein in Escherichia coli. J. Bacteriol. 169:1386-1390. (Pubitemid 17063459)
33. Lazzaroni JC, Atlan D, Portalier RC. 1985. Excretion of alkaline phosphatase by Escherichia coli K-12 pho constitutive mutants transformed with plasmids carrying the alkaline phosphatase structural gene. J. Bacteriol. 164:1376-1380. (Pubitemid 16207292)
34. O'Connell HA, Kottkamp GS, Eppelbaum JL, Stubblefield BA, Gilbert SE, Gilbert ES. 2006. Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm. Appl. Environ. Microbiol. 72:5013-5019. http://dx.doi.org/10.1128/AEM.02474-05. (Pubitemid 44078833)
35. Renneberg J, Walder M. 1989. The role of beta-lactamase in mixed infections in mice in relation to treatment with ampicillin. J. Infect. Dis. 160:337-341. http://dx.doi.org/10.1093/infdis/160.2.337. (Pubitemid 19189029)
36. Kataoka D, Fujiwara H, Kawakami T, Tanaka Y, Tanimoto A, Ikawa S. 2003. The indirect pathogenicity of Stenotrophomonas maltophilia. Int. J. Antimicrob. Agents 22:601-606. http://dx.doi.org/10.1016/S0924-8579(03)00244-9. (Pubitemid 37494996)
37. Westman E, Lundin S, Hermansson A, Melhus A. 2004. Beta-lactamase- producing nontypeable Haemophilus influenzae fails to protect Streptococcus pneumoniae from amoxicillin during experimental acute otitis media. Antimicrob. Agents Chemother. 48:3536-3542. http://dx.doi.org/10.1128/AAC.48.9.3536-3542. 2004. (Pubitemid 39129356)
38. Rodriguez-Hernandez MJ, Pachon J, Pichardo C, Cuberos L, Ibanez-Martinez J, Garcia-Curiel A, Caballero FJ, Moreno I, Jimenez-Mejias ME. 2000. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J. Antimicrob. Chemother. 45:493-501. http://dx.doi.org/10.1093/jac/45.4.493. (Pubitemid 30199143)